Mesenchymal stem cells (MSCs) are multipotent stromal cells that are capable of differentiate into multilineage cell types including bone in vitro and in vivo. Aim of the study: They have been widely developed as a therapeutic approach for bone tissue repair and regeneration. However, the efficiency of lineage specific differentiation still needs improvement. We investigated the effect of Tricin on the proliferation of human adult MSCs by alamar blue assay, the mineralization of MSCs by staining of calcium deposition, and the expression levels of the osteoblastic marker genes during osteogenic differentiation of MSCs. Moreover, we also checked the effects of Tricin on the expression of key genes in Wnt/β-catenin signaling pathway. We found Tricin could promote proliferation of MSCs, as well as their mineralization. Tricin could also enhance the expression of osteogenesis marker genes including Bone sialoprotein, osteocalcin, Alkaline phosphatase, and RUNX2. Furthermore, we found out that neither siβ-catenin nor GSK-3β had effect on Tricin treatment, but siWnt3α could neutralize the effect of Tricin. Tricin can enhance osteoblastogenesis through the regulation of Wnt/β-catenin signaling pathway in human adult MSCs in vitro.
Introduction
Mesenchymal stem cells (MSCs) are multipotent stromal cells that are capable of differentiate into multilineage cells in vitro and in vivo. They contribute to the regeneration of mesenchymal tissues including adipose, cartilage, tendon, muscle, and bone (Pittenger et al., 1999) . MSCs are characterized as a subpopulation marked for the profile of CD105 P et al., 2011) . MSCs can be isolated from bone marrow, adipose tissue, fetal tissues, amniotic fluid, and in fact it has been suggested that MSC-like cells exist in virtually all postnatal tissues and organs. In the event of an injury, the resident MSCs can move fast to the site and participate in the tissue repair and regeneration in tissues including skin, lung, bone, etc. (Borakati et al., 2018; Savukinas et al., 2016) . Bone undergoes constantly renew and regeneration (Duplomb et al., 2007) . Osteoclasts and osteoblasts coordinate and contribute to this dynamic process through lifetime. In situations of osteolytic bone tumor surgery, osteonecrosis, or after bone fractures, bone regeneration may exceed bone self-repair capacities. Thus bone tissue engineering is of great importance in medical research. The ability of able to differentiate into bone lineage and the accessibility makes MSCs an ideal candidate for in vitro bone tissue engineering and in vivo stem cell therapy (Garg et al., 2017; Yamasaki et al., 2014) . However, the efficiency of lineage specific differentiation is still in need to be improved. Compounds that can promote osteoblastogenic differentiation of MSCs are of great interest to researchers.
Tricin is a naturally occurring flavone, a constituent of rice bran and other grass species (Bickoff et al., 1964) . Preliminary safety evaluation for Tricin has showed no pathological or morphological changes in any murine tissues studied, it also lacked genotoxic properties in their study (Verschoyle et al., 2006) . Commercially it has been wide used in joint health supply. But the underline mechanism of how Tricin can promote joint/bone health is unclear. In this study, we aim to study the effects of Tricin on osteoblastogenic differentiation of MSC and try to elucidate the underlying mechanisms.
Results

Tricin promotes proliferation of MSCs
First we tested the effect of Tricin on proliferation of MSCs. Compared with the standard growth medium (GM) group, cells treated with Tricin showed increased proliferation (Fig. 1A) within 15 μM in the dose range we tested. At 15 μM Tricin it showed the most potent effect on MSC proliferation. However, the effect decreased while Tricin concentration beyond 15 μM, up to 25 μM. Tricin at the concentration
